Advertisement
pawan kumar nahar
Pawan Kumar Nahar

Pawan Kumar Nahar

pawan.nahar@aajtak.com

Pawan Nahar is a financial journalist with over a decade in journalism, saying good morning to BSE's Sensex and NSE Nifty50. Keen follower of IPOs, he also tracks cryptos, and personal finance — covering everything one can invest in. Known for due diligence and fluent Hindi, he blends insight with engaging storytelling. A YouTube learner beyond work, he enjoys cooking, poetry, traveling, and gaming.

SHOW MORE...

NIM recovery delayed but NII growth potentially bottomed out. NII growth has been trailing loan growth for multiple quarters now due to pressure on NIM.

Q3 banking preview: YES Bank, Bandhan Bank, IndusInd Bank may see soft Dec quarter

by Pawan Kumar Nahar |Dec 30, 2025

ICICI Securities forecasts a relatively stronger Q3FY26 for SBI, Kotak Mahindra Bank, City Union Bank, and Karur Vysya Bank, while IndusInd Bank, Yes Bank, and Bandhan Bank could see softer results.

SME IPO fund-raising has expanded even faster at a 46% CAGR, reflecting a more inclusive primary market ecosystem.

India's IPO market leads globally in 2025, momentum may continue in 2026, says Pantomath

by Pawan Kumar Nahar |Dec 30, 2025

India’s equity capital markets have experienced a significant transformation between 2020 and 2025, according to the Primary Pulse 2025 report by Pantomath Capital.

Ambit expects more share sales by strategic investors in JPL, Airtel, and Hexacom between 2026 and 2028, with government divestment from VI only likely after 2028.

RIL, Airtel, Vodafone, Indus Tower: Ambit ups EPS forecast; check ratings & price targets

by Pawan Kumar Nahar |Dec 30, 2025

Ambit has revised its outlook for India's telecom sector, increasing its FY25-42 revenue CAGR estimate by 1% as decisive government support for Vodafone Idea continues.

Broader markets displayed mixed trends, with midcaps showing relative resilience, while small-caps witnessed sharper bouts of volatility.

Stock picks 2026: Eternal, SBI, HCL Tech, Airtel, Biocon among top bets by Motilal Oswal

by Pawan Kumar Nahar |Dec 30, 2025

Motilal Oswal Wealth Management has shared its top picks for the new year 2026 as Indian equity markets have turned volatile, with Nifty ending 2025 with mild gains.

Incorporated in 2019, Gujarat Kidney and Super Speciality specialize in providing healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.

Gujarat Kidney & Super Speciality shares make decent D-st debut; stock lists at 6% premium

by Pawan Kumar Nahar |Dec 30, 2025

Gujarat Kidney & Super Speciality sold its shares in the price band of Rs 108-114 apiece, applied for a minimum of 128 shares and its multiples to raise Rs 250.80 crore between December 22-24.

Hindustan Copper is currently trading well above all its key moving averages, indicating that the broader trend remains strong, said the analyst.

Hindustan Zinc, Vedanta, Hindustan Copper: How to trade these buzzing metal stocks

by Pawan Kumar Nahar |Dec 30, 2025

An analyst from Anand Rathi said that Vedanta is quoting significantly above its key moving averages at the present stage, highlighting the strength of the prevailing uptrend.

The US dollar was steady on Tuesday ahead of the Federal Reserve's release of its December minutes report. The index was at 98.033 in early trading, not far from a three-month low.

Stock market today: Gift Nifty down 35 points; key levels for Nifty, Sensex & Nifty Bank

by Pawan Kumar Nahar |Dec 30, 2025

Nifty futures on the NSE International Exchange traded 34.70 points, or 0.13 per cent, down at 25,922.50, hinting at a muted start for the domestic market on Tuesday.

Gujarat Kidney & Super Speciality will make its stock market debut on Tuesday, December 30, after the healthcare services firm raised Rs 250.80 crore via IPO between December 22-24, selling its shares for Rs 114 apeice.

Top stocks in news: BEL, Gujarat Kidney, Grasim, Lupin, RVNL, Waaree, NTPC Green, Afcons

by Pawan Kumar Nahar |Dec 30, 2025

Stocks including Bharat Electronics, Gujarat Kidney, Grasim, Lupin, Waaree Energies, NTPC Green, Afcons Infra, Timex India and more will be in the spotlight on Tuesday, December 30.

Incorporated in 2019, Gujarat Kidney and Super Speciality specialize in providing healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.

Gujarat Kidney & Super Speciality IPO shares to list today; check latest GMP before debut

by Pawan Kumar Nahar |Dec 30, 2025

Gujarat Kidney & Super Speciality sold its shares in the price band of Rs 108-114 apiece, applied for a minimum of 128 shares and its multiples to raise Rs 250.80 crore between December 22-24.

Shares of Lenskart Solutions were listed on stock markets on November 10, 2025, as the company raised a total of Rs 7,278 crore via IPO by selling its shares of Rs 402 apeice

Lenskart shares: Brokerages initiate coverage with macro tailwinds; upside remains capped

by Pawan Kumar Nahar |Dec 29, 2025

Recently listed new age eyewear retailer Lenskart Solutions has attracted fresh brokerage interest lately including Emkay Global Financial Services and Avendus Spark.